drugset / Trial / NCT01453569

Safety, Efficacy and Dose Titration of Sodium Oligo-mannurarate Capsule on Mild to Moderate Alzheimer's Disease

NCT01453569

RandomizedParallel-groupTriple-blindTreatment

Summary

The primary purpose of this study is to determine whether sodium oligo-mannurarate capsule is effective and safe in the treatment of mild to moderate alzheimer' disease, and to determine the best therapeutic dose of sodium oligo-mannurarate capsule.

Timeline

Start
2011-10
Primary completion
2013-08
Completion
2013-08

Drugs

EvaluationDrugModalityDoseRoute
Subject GV-971 Other / unclassified 600 mg Oral
Subject GV-971 Other / unclassified 900 mg Oral

Indications